<DOC>
	<DOCNO>NCT00599807</DOCNO>
	<brief_summary>This 2-year double-blind randomize control trial 287 community-dwelling individual age 60 year old undergo uni-lateral total knee replacement due severe OA knee.We compare oral dose 2000 IU vitamin D3 per day 800 IU . The primary endpoint pain disability relate rehabilitation operate knee , relate expect high prevalence OA contra-lateral knee . Secondary endpoint change 25 ( OH ) D level , muscle strength , balance , low extremity function , rate fall , bone density bone quality , bone metabolism , general pain , fall-related fracture , body composition , blood-pressure , major cardiovascular event , blood glucose-insulin level , executive cognitive function , rate upper respiratory tract infection / infection , tooth loss , dental health , health care utilization , number size facial skin keratosis , radiographic progression non-operated knee . Pain disability assess pain function subscales Western Ontario- McMaster Universities Osteoarthritis Index ( WOMAC ) . Randomization stratify WOMAC function prior surgery , radiological evidence OA contra-lateral knee , hospital . Clinical visit take place baseline ( 6-8 week TKR ) , 6 , 12 , 18 24 month treatment . In addition , individual receive phone call every 2 month assess adverse outcome compliance treatment , support hotline immediate report adverse event . Statistical power : We expect 80 % power 200 participant complete 24 month follow-up , 260 participant complete 12 month follow-up . This trial medicinal product .</brief_summary>
	<brief_title>Zurich Multiple Endpoint Vitamin D Trial Knee OA Patients</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>Unilateral knee replacement due knee osteoarthritis Age 60+ year German language skill community dwell Bilateral knee replacement hip replacement plan trial period , previous 6 month Chronic steroid intake Serum calcium correct serum albumin &gt; 2.6 mmol/l GFR &lt; 30 ml/min Severe visual hearing impairment Inflammatory arthritis Malabsorption High alcohol intake Sarcoidosis , primary hyperparathyroidism History kidney stone , lymphoma Chemotherapy cancer previous 12 month Hemiplegia Morbus Parkinson Unable walk 3 meter prior surgery Bisphosphonate , parathyroid hormone , fluoride calcitonine therapy last 6 month Zolendronate last year M. Paget ( Ostitis deformans ) Vitamin D3 intake 800IU/d 1 month stay sunny location 6 week per year heart failure</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>